VERIFY Stroke Recovery Study
Principal Investigator: Michael Lyerly
Stroke recovery varies dramatically from person to person, making it difficult to predict outcomes and tailor rehabilitation approaches. This study seeks to move beyond “one-size-fits-all” rehabilitation by identifying objective brain-based biomarkers that may help clinicians better predict recovery trajectories and develop more personalized treatment strategies for stroke survivors.
Researchers at the Birmingham VA are participating in a large national study called VERIFY (Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials), which aims to improve prediction of arm and hand recovery after ischemic stroke. The study is evaluating whether advanced brain biomarkers can help clinicians better predict long-term motor recovery and personalize rehabilitation strategies earlier after stroke.
Stroke remains one of the leading causes of long-term disability in the United States, and many survivors experience lasting weakness or impaired function in the upper extremities. Currently, physicians often have limited tools to accurately predict how much recovery a patient may achieve in the weeks and months after stroke. Researchers hope this study will help identify biological markers that can guide treatment decisions and improve rehabilitation planning.
The VERIFY study combines clinical assessments with advanced MRI imaging and transcranial magnetic stimulation (TMS), a non-invasive technique used to measure communication between the brain and muscles. Investigators are specifically studying the integrity of the corticospinal tract and motor cortex pathways that control arm and hand movement.
Researchers are also validating the PREP2 prediction tool, which combines physical examination findings with brain biomarker data to estimate recovery potential after stroke. By creating one of the largest prospective datasets of stroke recovery biomarkers to date, the study may help future clinical trials identify patient subgroups more likely to benefit from targeted rehabilitation therapies.
The multicenter study plans to enroll up to 657 participants across approximately 45 sites nationwide. Participants undergo assessments during the acute stroke period and return for follow-up evaluations approximately 90 days later to measure recovery in motor impairment, functional ability, and real-world arm use.
ClinicalTrials.gov ID: NCT05338697
